Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anixa Biosciences

2.73
+0.01000.37%
Volume:46.73K
Turnover:129.18K
Market Cap:87.89M
PE:-6.94
High:2.80
Open:2.79
Low:2.72
Close:2.72
Loading ...
Jan 04, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 04, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 08, 2022

Major Issues Report

8-K - Current report
Sep 29, 2022

Major Issues Report

8-K - Current report
Sep 15, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 17, 2022

Major Issues Report

8-K - Current report
Jun 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2022

Major Issues Report

8-K - Current report
Mar 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 11, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 04, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 03, 2021

Beneficial Ownership Change

Anixa Biosciences Inc
Sep 01, 2021

Quarterly Report

Anixa Biosciences Inc
Jul 28, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 27, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities